E4630
乙胺丁醇 二盐酸盐
antimycobacterial
别名:
2,2＃8242;-(1,2- Ethanediyldiimino）双-1-丁醇 二盐酸盐, Emb
登录 查看组织和合同定价。
选择尺寸
变更视图
关于此项目
经验公式（希尔记法）:
C10H24N2O2 · 2HCl
化学文摘社编号:
分子量:
277.23
NACRES:
NA.85
PubChem Substance ID:
UNSPSC Code:
51281511
EC Number:
213-970-7
MDL number:
Quality Level
form
powder
optical activity
[α]25/D 6.0 to 6.7°, c = 10 in water
color
white
solubility
H2O: 50 mg/mL
antibiotic activity spectrum
mycobacteria
mode of action
cell wall synthesis | interferes
SMILES string
CC[C@@H](CO)NCCN[C@H](CO)CC.Cl.Cl
InChI
1S/C10H24N2O2.2ClH/c1-3-9(7-13)11-5-6-12-10(4-2)8-14;;/h9-14H,3-8H2,1-2H3;2*1H/t9-,10-;;/m0../s1
InChI key
AUAHHJJRFHRVPV-BZDVOYDHSA-N
Application
乙胺丁醇是一种分枝杆菌抗菌剂，与其他抗生素联合使用可治疗结核病，减缓耐药性的发展进程。
乙胺丁醇是一种分枝杆菌抗菌剂，与其他抗生素联合使用可治疗结核病，减缓耐药性的发展进程。在中国结核病发病率最高的地区，长期用于研究耐多药结核病（MDR-TB）。
Biochem/physiol Actions
乙胺丁醇对活跃生长的结核杆菌具有抗菌作用。分枝菌酸附着在阿拉伯半乳聚糖的 D-阿拉伯糖残基的 5′-羟基上，并在细胞壁中形成分枝酸- 阿拉伯半乳糖-肽聚糖复合层。乙胺丁醇通过抑制阿拉伯糖基转移酶，特别是分枝杆菌中的阿拉伯糖基转移酶，干扰阿拉伯半乳聚糖的合成，通过干扰分枝杆菌细胞壁中的阿拉伯半乳聚糖的生物合成，并导致细胞壁渗透性增加。
乙胺丁醇特异性抑制分枝杆菌中的阿拉伯糖基转移酶，干扰分枝杆菌细胞壁中的阿拉伯半乳聚糖的生物合成。
signalword
Warning
hcodes
Hazard Classifications
Acute Tox. 4 Oral
存储类别
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
ppe
Eyeshields, Gloves, type P3 (EN 143) respirator cartridges
Hassan Safi et al.
Nature genetics, 45(10), 1190-1197 (2013-09-03)
To study the evolution of drug resistance, we genetically and biochemically characterized Mycobacterium tuberculosis strains selected in vitro for ethambutol resistance. Mutations in decaprenylphosphoryl-β-D-arabinose (DPA) biosynthetic and utilization pathway genes Rv3806c, Rv3792, embB and embC accumulated to produce a wide
Mohammed Shafik El-Ridy et al.
Drug delivery, 22(1), 21-36 (2013-12-24)
Tuberculosis (TB) is a worldwide health concern. In 2011, about 8.7 million new cases developed TB and 1.4 million people died from it. Enhancement of ethambutol hydrochloride activity and safety in treatment of TB through niosomal encapsulation. Niosomes were prepared
Joshua R Francis et al.
The Medical journal of Australia, 200(6), 328-332 (2014-04-08)
OBJECTIVE To describe the epidemiology, clinical features, health care resource use, treatment and outcomes of multidrug-resistant tuberculosis (MDR-TB) cases diagnosed in Western Australia, compared with matched controls with drug-susceptible TB. Retrospective case-control study of all MDR-TB cases notified in WA
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| E4630-100G | 04061833603857 |
| E4630-25G | 04061833603864 |